Intellectual Property

  • February 09, 2026

    USPTO Targets Double-Dipping In Anon. Ex Parte Challenges

    The U.S. Patent and Trademark Office is now requiring those who anonymously petition it to reexamine a patent's validity to certify that they haven't already challenged it at the Patent Trial and Appeal Board.

  • February 09, 2026

    Videographer Fights 4th Circ.'s Choice To Shipwreck IP Suit

    A videographer and his production company urged the full Fourth Circuit to let him revive his copyright infringement lawsuit over footage of Blackbeard's shipwreck, arguing Monday that a panel's recent opinion to end the case laid new and overly broad pathways for pendent jurisdiction. 

  • February 09, 2026

    Fed. Circ. Won't Reboot Startup's Patent Suit Against Shopify

    The Federal Circuit on Monday declined to breathe new life into a case from a defunct digital media startup alleging that Shopify was infringing its patents by using ideas disclosed during talks about a potential partnership.

  • February 09, 2026

    Fed. Circ. Sends Blood Pump Patent Fight Back To Mass.

    The Federal Circuit on Monday reversed a lower court's ruling that Abiomed Inc. hasn't infringed five patents on blood pump systems and methods, while backing the part of the decision that cleared the medical device technology company of allegations it infringed a different patent.

  • February 09, 2026

    'Baby Shark' Ruling Doesn't Stop Google Anti-Phishing Fight

    A Manhattan federal judge granted injunctive relief Monday to Google in its effort to combat an alleged China-based phishing enterprise, holding that faraway defendants were properly served electronically despite an appellate ruling mandating mail service in a "Baby Shark" infringement case.

  • February 09, 2026

    Novo Nordisk Sues Hims & Hers Over Knockoff GLP-1

    Novo Nordisk AS followed through on Monday in Delaware federal court on a plan it announced last week to sue telehealth company Hims & Hers Health Inc. over its marketing of what Novo Nordisk calls a knockoff version of its GLP-1 medications.

  • February 09, 2026

    Intellectual Property Group Of The Year: Susman Godfrey

    Susman Godfrey LLP attorneys in the past year achieved some of the most closely watched victories in copyright, privacy and life sciences, including a record-setting copyright class settlement over books Anthropic obtained to train its flagship artificial intelligence model, earning the firm a spot among the 2025 Law360 Intellectual Property Groups of the Year.

  • February 09, 2026

    High Court Asked To Take Up Malpractice Case Against Akin

    A former Cornell University graduate student wants the U.S. Supreme Court to review the dismissal of his suit accusing Akin Gump Strauss Hauer & Feld LLP attorneys of manipulating patent litigation to steal his DNA sequencing intellectual property.

  • February 06, 2026

    Takeda Can't Ax Most Of Heartburn Drug Pay-For-Delay Suit

    Takeda Pharmaceutical Co. and TWi Pharmaceuticals must face most of a proposed antitrust class action accusing them of delaying the release of the generic version of Takeda's heartburn medication Dexilant, causing Walgreens, Kroger and other retailers to pay more for the brand-name drug, a California federal judge ruled Friday.

  • February 06, 2026

    OpenAI Can Keep Atty Comms Secret After All, Judge Says

    A New York federal judge Friday set aside a magistrate judge's order requiring OpenAI's in-house attorneys to share their internal communications regarding deleted training datasets with authors suing over alleged copyright infringement, holding that the conclusions underlying that decision were "clearly erroneous or contrary to law."

  • February 06, 2026

    HHS Refers Hims & Hers To DOJ Amid Compound Drug Fight

    U.S. Department of Health and Human Services general counsel Mike Stuart announced Friday that his office referred Hims & Hers Health Inc. to the U.S. Department of Justice for investigation, a day after Novo Nordisk A/S threatened litigation over what it called the telehealth company's "knockoff" version of its popular weight loss drug Wegovy.

  • February 06, 2026

    Squires Rules Inconsistent Claim Constructions Doom 3 IPRs

    U.S. Patent and Trademark Office Director John Squires has undone three decisions by the Patent Trial and Appeal Board instituting inter partes reviews, finding that the patent challengers made conflicting claim construction arguments in the reviews and in court.

  • February 06, 2026

    'Very Bizarre': Trump's Funding Freeze Appeal Vexes DC Circ.

    D.C. Circuit judges struggled Friday with whether to unblock a federal funding freeze carrying multitrillion-dollar implications, as a Trump administration lawyer disclaimed interest in a vast spending halt but also dodged opportunities to rule it out unequivocally.

  • February 06, 2026

    NJ Judge Tosses Pacira Investor Suit Over Patent Loss

    A New Jersey federal judge on Friday threw out an investor lawsuit against Pacira BioSciences Inc. after a court invalidated a patent for its key pain management drug, ruling that the pharmaceutical company was not required to disclose litigation setbacks it encountered before the final ruling.

  • February 06, 2026

    Tesla, X Accused Of Infringing Voice Assistance Tech Patent

    Tesla Inc., X Corp., and an Indian technology company were all hit with patent infringement lawsuits in Texas federal court over their technology that uses voice assistance.

  • February 06, 2026

    Skating, Twirling And Juggling IP Risk At The Winter Olympics

    Snowboarders, figure skaters, curlers and other competitive athletes have been training for years to be ready for the unexpected at the Winter Olympics, but intellectual property issues arising from taking part in the global sporting event are probably not high on their priority list.

  • February 06, 2026

    PTAB Tosses 2nd Patent On Cologuard Colon Cancer Test

    The Patent Trial and Appeal Board has found that Geneoscopy had shown that all the claims it challenged in a patent on Exact Sciences' colon cancer test Cologuard are invalid as obvious, months after the PTAB invalidated claims in a similar patent.

  • February 06, 2026

    'Cardiac Pack' Wants NC Justices To Revive NIL Suit

    A group of former student-athletes from the early 1980s is urging North Carolina's highest court to revive their name, image and likeness lawsuit against the NCAA, arguing the organization's use of gameplay footage to advertise March Madness is a continuing harm.

  • February 06, 2026

    Tesla, Musk Must Face 'Blade Runner 2049' Copyright Suit

    A Los Angeles federal judge has declined Tesla and Elon Musk's request to throw out a copyright complaint accusing them of using imagery from the movie "Blade Runner 2049" to create a visual for a Tesla promotional event.

  • February 06, 2026

    Fed. Circ. Clears E-Tracking Patents In Apple PTAB Challenge

    The Federal Circuit on Friday rejected Apple's appeal of a Patent Trial and Appeal Board decision that upheld claims in an LBT patent for electronic location tracking.

  • February 06, 2026

    Squires Revives Dish Patent Over Pornhub RPI Error

    U.S. Patent and Trademark Office Director John Squires has vacated the Patent Trial and Appeal Board's invalidation of a Dish Technologies LLC streaming patent, saying it took too long to disclose a real party in interest.

  • February 06, 2026

    Jury Awards $8.4M In Oilfield Trade Secrets Theft Case

    A Texas federal jury has handed an oilfield services company $8.4 million in damages after finding a rival had willfully pilfered trade secrets related to nitrogen rejection unit technology when an employee left to start the rival firm.

  • February 06, 2026

    NH Supreme Court Upholds $23 Million Nokia Oral Deal

    The New Hampshire Supreme Court has affirmed a $23 million award a federal jury granted to Collision Communications against Nokia, representing the amount allegedly agreed upon in an over-the-phone deal made for patent licenses in 2017.

  • February 06, 2026

    Rupp Marine Didn't Infringe Fishing Line Patents, Judge Rules

    A Florida federal judge has ruled that marine supply store Rupp Marine Inc. did not infringe patents owned by Gem Products LLC for line management systems for fishing boats with outriggers.

  • February 06, 2026

    Fed. Circ. Backs Target's Alice Win Over Product Location IP

    The Federal Circuit on Friday refused to revive claims in a series of patents covering ways of finding products within a store, backing a lower court's finding that Target was able to show the claims were invalid under the U.S. Supreme Court's Alice standard.

Expert Analysis

  • Fed. Circ. In August: A Framework For AIA Derivation Disputes

    Author Photo

    In Global Health Solutions v. Selner, the Federal Circuit established how to assess derivation challenges under the America Invents Act's first-to-file system, making it easier for petitioners to determine a challenge's odds of success, say attorneys at Knobbe Martens.

  • USPTO's Track One A Reliable Patent Pathway Amid Backlog

    Author Photo

    As the U.S. Patent and Trademark Office faces a backlog of unexamined utility, plant and reissue patent applications, patent applicants should consider utilizing the USPTO's Track One Program, which not only expedites the process but also increases the likelihood of working with more senior examiners, says Ryan Schermerhorn at Marshall Gerstein.

  • How New Rule On Illustrative Aids Is Faring In Federal Courts

    Author Photo

    In the 10 months since new standards were codified for illustrative aids in federal trials, courts have already begun to clarify the rule's application in different contexts and the rule's boundaries, say attorneys at Bernstein Litowitz.

  • What Novel NIL Suit Reveals About College Sports Landscape

    Author Photo

    A first-of-its-kind name, image and likeness lawsuit — recently filed in Wisconsin state court by the University of Wisconsin-Madison against the University of Miami — highlights new challenges and risks following the NCAA’s landmark agreement to allow schools to make NIL deals and share revenue with student-athletes, say attorneys at O'Melveny.

  • Series

    Law School's Missed Lessons: Mastering Time Management

    Author Photo

    Law students typically have weeks or months to prepare for any given deadline, but the unpredictability of practicing in the real world means that lawyers must become time-management pros, ready to adapt to scheduling conflicts and unexpected assignments at any given moment, says David Thomas at Honigman.

  • How Hyperlinks Are Changing E-Discovery Responsibilities

    Author Photo

    A recent e-discovery dispute over hyperlinked data in Hubbard v. Crow shows how courts have increasingly broadened the definition of control to account for cloud-based evidence, and why organizations must rethink preservation practices to avoid spoliation risks, says Bree Murphy at Exterro.

  • Beaming Up Lessons From William Shatner's Failed Patent Bid

    Author Photo

    In a tale that boldly goes where few celebrity inventors have gone before, William Shatner's unsuccessful attempt to patent a smartphone file organization system offers insights about potential pitfalls to avoid in patent applications, say attorneys at King & Spalding.

  • The Pros And Cons Of Levying Value-Based Fees On Patents

    Author Photo

    The potential for a recurring, value-based maintenance fee on patents, while offering some benefits, raises several complications, including that it would likely exceed the U.S. Patent and Trademark Office's statutory authority and reduce research and development activities in the U.S., says Sandip Patel at Marshall Gerstein.

  • Strategies To Get The Most Out Of A Mock Jury Exercise

    Author Photo

    A Florida federal jury’s recent $329 million verdict against Tesla over a fatal crash demonstrates how jurors’ perceptions of nuanced facts can make or break a case, and why attorneys must maximize the potential of their mock jury exercises to pinpoint the best trial strategy, says Jennifer Catero at Snell & Wilmer.

  • Series

    Writing Musicals Makes Me A Better Lawyer

    Author Photo

    My experiences with writing musicals and practicing law have shown that the building blocks for both endeavors are one and the same, because drama is necessary for the law to exist, says Addison O’Donnell at LOIS Law.

  • Between The Lines Of EPO's Adoption Of Color Drawings

    Author Photo

    The European Patent Office's decision to accept patent drawings in color starting in October may enhance clarity in technical disclosures and streamline the examination process, and could also enable new patent filing strategies for international applicants, say attorneys at Miller Canfield.

  • Series

    Adapting To Private Practice: From Va. AUSA To Mid-Law

    Author Photo

    Returning to the firm where I began my career after seven years as an assistant U.S. attorney in Virginia has been complex, nuanced and rewarding, and I’ve learned that the pursuit of justice remains the constant, even as the mindset and client change, says Kristin Johnson at Woods Rogers.

  • 2 Fed. Circ. Rulings Underscore Patent Prosecution Pitfalls

    Author Photo

    Two recent patent decisions from the Federal Circuit, overturning significant judgments, serve as reminders that claim modifications and cancellations may have substantive effects on the scope of other claims, and that arguments distinguishing prior art and characterizing claims may also limit claim scope, say attorneys at Morgan Lewis.

  • 7 Document Review Concepts New Attorneys Need To Know

    Author Photo

    For new associates joining firms this fall, stepping into the world of e-discovery can feel like learning a new language, but understanding a handful of fundamentals — from coding layouts to metadata — can help attorneys become fluent in document review, says Ann Motl at Bowman and Brooke.

  • Fed. Circ. Rulings Refine Patent Claim Construction Standards

    Author Photo

    Four Federal Circuit patent decisions this year clarify several crucial principles governing patent claim construction, including the importance of prosecution history, and the need for error-free, precise language from claims drafters, say attorneys at Taft.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.